Suppr超能文献

动脉僵硬度的机制:从力学转导到表观遗传学。

Mechanisms of Arterial Stiffening: From Mechanotransduction to Epigenetics.

机构信息

From the INSERM, U1116, Vandœuvre-lès-Nancy, France (P.L., V.R.).

Université de Lorraine, Nancy, France (P.L., V.R.).

出版信息

Arterioscler Thromb Vasc Biol. 2020 May;40(5):1055-1062. doi: 10.1161/ATVBAHA.119.313129. Epub 2020 Feb 20.

Abstract

Arterial stiffness is a major independent risk factor for cardiovascular complications causing isolated systolic hypertension and increased pulse pressure in the microvasculature of target organs. Stiffening of the arterial wall is determined by common mechanisms including reduced elastin/collagen ratio, production of elastin cross-linking, reactive oxygen species-induced inflammation, calcification, vascular smooth muscle cell stiffness, and endothelial dysfunction. This brief review will discuss current biological mechanisms by which other cardiovascular risk factors (eg, aging, hypertension, diabetes mellitus, and chronic kidney disease) cause arterial stiffness, with a particular focus on recent advances regarding nuclear mechanotransduction, mitochondrial oxidative stress, metabolism and dyslipidemia, genome mutations, and epigenetics. Targeting these different molecular pathways at different time of cardiovascular risk factor exposure may be a novel approach for discovering drugs to reduce arterial stiffening without affecting artery strength and normal remodeling.

摘要

动脉僵硬度是心血管并发症的一个主要独立风险因素,可导致孤立性收缩期高血压和靶器官微血管脉搏压升高。动脉壁僵硬度由包括弹性蛋白/胶原比例降低、弹性蛋白交联产生、活性氧诱导炎症、钙化、血管平滑肌细胞僵硬和内皮功能障碍等常见机制决定。这篇简要综述将讨论其他心血管风险因素(如衰老、高血压、糖尿病和慢性肾脏病)导致动脉僵硬度的当前生物学机制,特别关注核机械转导、线粒体氧化应激、代谢和血脂异常、基因组突变和表观遗传学方面的最新进展。针对心血管风险因素暴露的不同时间点的这些不同分子途径,可能是发现药物以减少动脉僵硬度而不影响动脉强度和正常重塑的新方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验